Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

368

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

AgricultureNews

Court Upholds Removal of Pro-GMO AFAN President After 6-Year Unlawful Tenure

The Court of Appeal in Abuja has upheld the removal of Kabir...

The staff of the National Agency for Food and Drug Administration and Control (NAFDAC) have embarked on an indefinite nationwide strike, following the expiration of a 14-day ultimatum issued to the agency’s management
HealthNews

Nigeria’s House of Reps Grills NAFDAC Over Unequal Drug Raid Enforcement, Revenue Transparency

The House of Representatives Committee on Food and Drug Administration and Control...

NewsSports

Nigeria’s D’Tigress Defeat Cameroon to Reach AfroBasket Semis, Secure World Cup Qualifier Spot

Nigeria’s D’Tigress continued their dominant march toward a historic fifth consecutive FIBA Women’s...